232 related articles for article (PubMed ID: 37834936)
1. Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease.
West J; Tan K; Devi J; Macrae F; Christensen B; Segal JP
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834936
[TBL] [Abstract][Full Text] [Related]
2. Treat to target in Crohn's disease: A practical guide for clinicians.
Srinivasan AR
World J Gastroenterol; 2024 Jan; 30(1):50-69. PubMed ID: 38293329
[TBL] [Abstract][Full Text] [Related]
3. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Turner D; Ricciuto A; Lewis A; D'Amico F; Dhaliwal J; Griffiths AM; Bettenworth D; Sandborn WJ; Sands BE; Reinisch W; Schölmerich J; Bemelman W; Danese S; Mary JY; Rubin D; Colombel JF; Peyrin-Biroulet L; Dotan I; Abreu MT; Dignass A;
Gastroenterology; 2021 Apr; 160(5):1570-1583. PubMed ID: 33359090
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review.
Colombel JF; D'haens G; Lee WJ; Petersson J; Panaccione R
J Crohns Colitis; 2020 Feb; 14(2):254-266. PubMed ID: 31403666
[TBL] [Abstract][Full Text] [Related]
5. Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?
Agrawal M; Colombel JF
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):421-436. PubMed ID: 31078245
[TBL] [Abstract][Full Text] [Related]
6. Review article: Translating STRIDE-II into clinical reality - Opportunities and challenges.
Dignass A; Rath S; Kleindienst T; Stallmach A
Aliment Pharmacol Ther; 2023 Sep; 58(5):492-502. PubMed ID: 37382397
[TBL] [Abstract][Full Text] [Related]
7. Shooting for the Stars: Review of the STARDUST Trial and the Treat-to-Target Approach for Crohn's Disease.
Shawn G; Hou JK
Gastroenterol Hepatol (N Y); 2022 May; 18(5):243-247. PubMed ID: 36397755
[TBL] [Abstract][Full Text] [Related]
8. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Peyrin-Biroulet L; Sandborn W; Sands BE; Reinisch W; Bemelman W; Bryant RV; D'Haens G; Dotan I; Dubinsky M; Feagan B; Fiorino G; Gearry R; Krishnareddy S; Lakatos PL; Loftus EV; Marteau P; Munkholm P; Murdoch TB; Ordás I; Panaccione R; Riddell RH; Ruel J; Rubin DT; Samaan M; Siegel CA; Silverberg MS; Stoker J; Schreiber S; Travis S; Van Assche G; Danese S; Panes J; Bouguen G; O'Donnell S; Pariente B; Winer S; Hanauer S; Colombel JF
Am J Gastroenterol; 2015 Sep; 110(9):1324-38. PubMed ID: 26303131
[TBL] [Abstract][Full Text] [Related]
9. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.
Bryant RV; Winer S; Travis SP; Riddell RH
J Crohns Colitis; 2014 Dec; 8(12):1582-97. PubMed ID: 25267173
[TBL] [Abstract][Full Text] [Related]
10. Definition and evaluation of mucosal healing in clinical practice.
Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of mucosal healing for the management of IBD.
Pineton de Chambrun G; Peyrin-Biroulet L; Lémann M; Colombel JF
Nat Rev Gastroenterol Hepatol; 2010 Jan; 7(1):15-29. PubMed ID: 19949430
[TBL] [Abstract][Full Text] [Related]
12. Development of a Software for Treat-To-Target Strategy Implementation and Increasing Quality of Life in Patients with Inflammatory Bowel Disease.
Popa DE; Manea NC; Gheonea DI; PÎrlog MC
Curr Health Sci J; 2020; 46(2):103-110. PubMed ID: 32874680
[TBL] [Abstract][Full Text] [Related]
13. Limited uptake of ulcerative colitis "treat-to-target" recommendations in real-world practice.
Bryant RV; Costello SP; Schoeman S; Sathananthan D; Knight E; Lau SY; Schoeman MN; Mountifield R; Tee D; Travis SPL; Andrews JM
J Gastroenterol Hepatol; 2018 Mar; 33(3):599-607. PubMed ID: 28806471
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
15. Treatment to target in patients with inflammatory bowel disease. What is the evidence?
Frimor C; Kjeldsen J; Ainsworth M
Scand J Gastroenterol; 2020 May; 55(5):528-536. PubMed ID: 32503364
[No Abstract] [Full Text] [Related]
16. Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.
Christensen B; Rubin DT
Curr Gastroenterol Rep; 2016 Jan; 18(1):5. PubMed ID: 26759147
[TBL] [Abstract][Full Text] [Related]
17. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by "tight control"?
Gonczi L; Bessissow T; Lakatos PL
World J Gastroenterol; 2019 Nov; 25(41):6172-6189. PubMed ID: 31749591
[TBL] [Abstract][Full Text] [Related]
18. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
[TBL] [Abstract][Full Text] [Related]
19. Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.
Pineton de Chambrun G; Blanc P; Peyrin-Biroulet L
Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):915-27. PubMed ID: 27043489
[TBL] [Abstract][Full Text] [Related]
20. Treat to target in inflammatory bowel disease: a survey of treatment strategies amongst Portuguese doctors.
Bernardo S; Fernandes SR; Araújo-Correia L
Rev Esp Enferm Dig; 2019 Aug; 111(8):593-597. PubMed ID: 31190548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
